首页> 外文期刊>Modern Pathology >Follicular Lymphoma with Marginal Zone Differentiation: Microdissection Demonstrates the t(14;18) in Both the Follicular and Marginal Zone Components
【24h】

Follicular Lymphoma with Marginal Zone Differentiation: Microdissection Demonstrates the t(14;18) in Both the Follicular and Marginal Zone Components

机译:具有边缘区分化的滤泡性淋巴瘤:显微解剖表明滤泡和边缘区成分中的t(14; 18)

获取原文
       

摘要

On occasion, follicle center lymphomas (FCL) may contain a marginal-zone (MZ) component in which the interfollicular lymphoid cells take on an MZ cell morphology. In the past, these have been termed composite lymphomas. However, recent studies suggest that the two components are clonally related. It is unknown whether the bcl-2 translocation present in most FCLs is present in the cells that demonstrate MZ cell morphology. We have identified three cases of low-grade FCL with a MZ component suitable for laser capture microdissection (LCM) of the two components. Cases were immunophenotyped in paraffin section with antibodies to CD10, CD20, bcl-2, and bcl-6. LCM was done to isolate cells from each component. Polymerase chain reaction for t(14;18) using primers to the major breakpoint region was performed on DNA extracts. The sensitivity of the PCR assay was decreased to 5%–10% follicle center cells in a background of reactive tonsil cells. All three cases showed different phenotypes in each component. The FCL component was positive for all four of the above markers, whereas the MZ component expressed only CD20 and bcl-2. Both components showed t(14;18) amplicons of identical size, with the MZ component signal being stronger than the 5%–10% sensitivity control, suggesting that the signal was not from rare, contaminating FCL cells. These results confirm that both components are clonally related and support the theory that these are indeed FCLs with MZ differentiation (that retain the t(14;18)) rather than the reverse, MZ lymphoma with follicle center differentiation.
机译:有时,滤泡中心淋巴瘤(FCL)可能包含边缘区(MZ)成分,其中小泡间淋巴样细胞呈MZ细胞形态。在过去,这些被称为复合淋巴瘤。但是,最近的研究表明这两个组成部分是克隆相关的。尚不清楚大多数FCL中存在的bcl-2易位是否存在于显示MZ细胞形态的细胞中。我们已经确定了三例低级FCL,其中MZ组件适合于两个组件的激光捕获显微切割(LCM)。用针对CD10,CD20,bcl-2和bcl-6的抗体在石蜡切片中对病例进行免疫表型分析。进行LCM分离细胞中的每个成分。在DNA提取物中进行了针对主要断裂点区域的引物的t(14; 18)聚合酶链反应。在反应性扁桃体细胞的背景下,PCR测定的灵敏度降低到5 %– 10 %的卵泡中心细胞。这三种情况在每个成分中均表现出不同的表型。对于以上所有四个标记,FCL成分均为阳性,而MZ成分仅表达CD20和bcl-2。两种成分均显示相同大小的t(14; 18)扩增子,MZ成分信号比5 %– 10 %灵敏度对照强,表明该信号并非来自罕见的污染FCL细胞。这些结果证实了这两个成分在克隆上相关,并支持以下理论:它们确实是具有MZ分化的FCL(保留t(14; 18)),而不是具有卵泡中心分化的反向MZ淋巴瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号